ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Interaction of SENP6 with PINK1 Promotes Temozolomide Resistance in Neuroglioma Cells via Inducing the Mitophagy

Wang, Y. W.; Jia, K. G.; Xing, H. J.; Pan, Y.; Zeng, C. S.; Chen, L.; Su, Q. J.; Shen, W. T.; Chen, J.; Chen, C.*; Cao, Q.*; Wang, Y. Y.电子科技大学; 南方医科大学; 海南医学院
MOLECULAR BIOLOGY2023-12DOI: 10.1134/S0026893324010175
8阅读
引用收藏
分享

摘要

Temozolomide resistance is a major cause of recurrence and poor prognosis in neuroglioma. Recently, growing evidence has suggested that mitophagy is involved in drug resistance in various tumor types. However, the role and molecular mechanisms of mitophagy in temozolomide resistance in glioma remain unclear. In this study, mitophagy levels in temozolomide-resistant and -sensitive cell lines were evaluated. The mechanisms underlying the regulation of mitophagy were explored through RNA sequencing, and the roles of differentially expressed genes in mitophagy and temozolomide resistance were investigated. We found that mitophagy promotes temozolomide resistance in glioma. Specifically, small ubiquitin-like modifier specific protease 6 (SENP6) promoted temozolomide resistance in glioma by inducing mitophagy. Protein-protein interactions between SENP6 and the mitophagy executive protein PTEN-induced kinase 1 (PINK1) resulted in a reduction in small ubiquitin-like modifier 2 (SUMO2)ylation of PINK1, thereby enhancing mitophagy. Our study demonstrates that by inducing mitophagy, the interaction of SENP6 with PINK1 promotes temozolomide resistance in glioblastoma. Therefore, targeting SENP6 or directly regulating mitophagy could be a potential and novel therapeutic target for reversing temozolomide resistance in glioma.

学科与关键词

关键词
glioblastomatemozolomide resistanceSENP6mitophagyPINK1
相关
加载中…
  • Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
    Wei, Q. T.; Liu, B. Y.; Ji, H. Y.; Lan, Y. F.; Tang, W. H.; Zhou, J.; Zhong, X. Y.; Lian, C. L.; Huang, Q. Z.; Wang, C. Y.; Xu, Y. M.; Guo, H. B.*Molecular Therapy-Oncolytics, 2021, 22: 114-128.被引 18
  • Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction.
    Yamashiro, Kei; Nakao, Kazutaka; Ohba, Shigeo; Hirose, Yuichi*Anticancer Research, 2020, 40(3): 1315-1323.
  • Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
    Chen, Zigui; Yan, Xin; Miao, Changfeng; Liu, Longyang; Liu, Su; Xia, Ying*; Fang, Weiyi*; Zheng, Dandan*; Luo, Qisheng*Cancer Cell International, 2023, 23(1): 220.
查看全部 →

发表信息

论文状态
公开发表
期刊
MOLECULAR BIOLOGY
发表日期
2023-12
卷期
第 57 卷, 第 6 期
页码
1228-1238
DOI
10.1134/S0026893324010175
语言
ENGLISH
成果收录
SCIE
资助标注
Scientific Research Project of Hainan Health and Family Planning Industry [18A200175]; Key Research and Development Projects of Sichuan Science and Technology [2022YFS0221, 2022YFS0074, 2022YFS0156, 2022YFS0378]; Sichuan Provincial People's Hospital Hospital Young Talent Fund [2021QN08]

作者

  • W

    Wang, Y. W. (第一作者)

  • J

    Jia, K. G.

    sichuan prov peoples hosp · univ elect sci & technol china

查看全部 12 位作者收起作者
  • X

    Xing, H. J.

    2 · hainan med univ

  • P

    Pan, Y.

    2 · hainan med univ

  • Z

    Zeng, C. S.

    2 · hainan med univ

  • C

    Chen, L.

    2 · hainan med univ

  • S

    Su, Q. J.

    2 · hainan med univ

  • S

    Shen, W. T.

    southern med univ

  • C

    Chen, J.

  • C

    Chen, C. (通讯)

    2 · hainan med univ

  • C

    Cao, Q. (通讯)

  • W

    Wang, Y. Y.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417